The μ-opioid receptor induces miR-21 expression and is ERK/PKCμ-dependent

Jen-Kuan Chang1, William D Cornwell1, Thomas J Rogers1

  • 1Center for Inflammation, Translational and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.

Insights

MicroRNA-21 (miR-21) expression in monocytes is induced by the μ-opioid receptor (MOR). This process involves the Ras-Raf-MEK-ERK pathway and PKCμ (PKD1), impacting pain sensitivity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Neuroscience

Background:

  • MicroRNA-21 (miR-21) is implicated in the innate immune response, particularly in the transition from inflammation to resolution.
  • The precise molecular mechanisms driving miR-21 induction are not fully understood.
  • Activation of the μ-opioid receptor (MOR) has been linked to increased miR-21 expression.

Purpose of the Study:

  • To investigate the biochemical basis for μ-opioid receptor (MOR)-mediated induction of microRNA-21 (miR-21) expression in human monocytes.
  • To identify the specific signaling pathways involved in MOR-induced miR-21 expression.

Main Methods:

  • Human monocytes were treated with μ-opioid agonists.
  • miR-21 expression levels were measured.
  • The involvement of the Ras-Raf-MEK-ERK signaling cascade and PKCμ (PKD1) was assessed.

Main Results:

  • Treatment of human monocytes with μ-opioid agonists led to a significant increase in miR-21 expression.
  • MOR-induced miR-21 expression was dependent on the activation of the Ras-Raf-MEK-ERK signaling pathway.
  • Activation of PKCμ (PKD1) was also found to be essential for MOR-mediated miR-21 induction.

Conclusions:

  • The μ-opioid receptor (MOR) pathway, involving Ras-Raf-MEK-ERK and PKCμ (PKD1), is a key regulator of miR-21 expression in monocytes.
  • These findings provide novel insights into the molecular mechanisms underlying miR-21 regulation.
  • Understanding this pathway is significant for exploring the role of miR-21 in pain sensitivity and immune responses.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K